On July 5^th, 2016, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Fellow in the Field of Clinical Biochemistry (Approval Notice).

General Field: Clinical Biochemistry

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: India

Service Center: Texas Service Center (TSC)

State of Residence at the Time of Filing: Texas

Approval Notice Date: July 5^th, 2016

Processing Time: 5 months, 22 days (Premium Processing Requested)

Case Summary:

Nearly 6 months after North America Immigration Law Group (WeGreened.com) filed an EB-1A (Alien of Extraordinary Ability) petition on behalf of a postdoctoral fellow from India, Texas Service Center approved it. It would have taken the USCIS far longer to process his case had he not elected to upgrade it to Premium Processing (PP) five months in. PP allows for action to be taken on certain I-140 cases within 15 calendar days. In this case, our client received notification of case approval just 11 days after the upgrade. As the cherry on top of the cake, the USCIS did not issue a Request for Evidence (RFE), which attested to just how efficient and persuasive we were in presenting our client’s credentials.

Meeting the EB-1A requirements:

In order to qualify for EB-1A, one must meet at least three out of the 10 requirements set by the USCIS. As EB-1A is upheld by a very high standard of law, it is not easy meeting these requirements. Because our client has spent years in the field of clinical biochemistry, he has amassed an array of impressive professional accomplishments, making him a suitable candidate for this visa category. After evaluating his credentials, we determined that our client met the following requirements at the time of filing: high citation count (126 citations), notable publication record (10 published scientific articles), and experience judging the work of others (he had conducted 20 peer reviews).

We fortified our client’s EB-1A petition by including recommendation letters contributed by experts in the field whom we helped select. We made sure that these experts were familiar with our client’s work on the pathogenesis of prostate and pancreatic cancers and/or had worked with him. The six signed letters that our client collected contained statements such as these:

“[Client] has proven himself to be a leading researcher in cancer research here in the United States, as his work has positively impacted and garnered the attention of some of the country’s most authoritative institutions and organizations. It is in the best interests of the scientific research enterprise in the United States to retain [Client] and encourage his further efforts in cancer research.”

“… [Client’s] presence within the United States’ world-leading cancer research community is of great importance.”

We congratulate our client for obtaining an in-demand EB-1A petition approval, and we wish him well as he embarks on the final leg of the journey to permanent residency: filing an I-485 application.